Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Zhuoru Liang"'
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Objective: Statin is well-established as a classical lipid-lowering drug, and its cost has reduced considerably in the past years. Inclisiran is a new and effective lipid-lowering drug given as a subcutaneous injection at 6-month intervals. This stud
Externí odkaz:
https://doaj.org/article/48707b9559004d4f8119af69e70d31d5
Autor:
Tiantian Zhang, Zhuoru Liang, Tengfei Lin, David J. Cohen, Alejandro Arrieta, Xiaobin Wang, Xianhui Qin, Binyan Wang, Yong Huo, Gordon G. Liu, Jie Jiang, Zugui Zhang
Publikováno v:
BMC Medicine, Vol 20, Iss 1, Pp 1-14 (2022)
Abstract Background For hypertensive patients without a history of stroke or myocardial infarction (MI), the China Stroke Primary Prevention Trial (CSPPT) demonstrated that treatment with enalapril-folic acid reduced the risk of primary stroke compar
Externí odkaz:
https://doaj.org/article/e818d124d82847ea9a201bccbcc85b7f
Autor:
Xin Jiang, Jiahao Li, Jingmei Xie, Zhuoru Liang, Ning Wan, Jie Jiang, Tiantian Zhang, Yingyu Wu
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
Background: Endoscopic submucosal dissection (ESD) was commonly used for en bloc resection in gastric cancer and adenoma with the risk of delayed bleeding after ESD. We conducted a direct and indirect comparison meta-analysis to evaluate the best cho
Externí odkaz:
https://doaj.org/article/2af1651f634444fc9dd002ec21486820
Autor:
Dan Qian, Tiantian Zhang, Xiangping Tan, Peiying Zheng, Zhuoru Liang, Jingmei Xie, Jie Jiang, Bing Situ
Publikováno v:
PLoS ONE, Vol 13, Iss 8, p e0202563 (2018)
AIMS:This study aimed to investigate the efficacy and safety of dual therapy comprising sulfonylurea (SU) plus antidiabetic drugs for the treatment of type 2 diabetes mellitus (T2DM). METHODS:We searched the PubMed, Cochrane library, and Embase datab
Externí odkaz:
https://doaj.org/article/7ea18887402f4352834dd37cd8ff36a7
Autor:
Jie Jiang, Zhuoru Liang, Wenhua Liang, Tiantian Zhang, Ning Wan, Jiahao Li, Xudong Chen, Jiaxin Zhu
Publikováno v:
Immunotherapy. 12:1237-1246
Aim: To evaluate the cost–effectiveness of first-line treatments for advanced renal cell carcinoma with pembrolizumab plus axitinib compared with sunitinib from the US payer perspective. Patients & methods: A Markov model was developed for this pur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1348b846cdd8c29fe590b6e6be83f272
https://doi.org/10.2217/imt-2020-0034
https://doi.org/10.2217/imt-2020-0034
Autor:
Jingmei Xie, Sen Wang, Ning Wan, Zhuoru Liang, Jie Jiang, Tengfei Lin, Tiantian Zhang, Yaohua Cao
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:e478-e488
Many new regimens have been applied to newly diagnosed transplant-ineligible multiple myeloma, but no head-to-head research has been performed to compare the efficacy of these treatments. Currently lenalidomide plus dexamethasone (Rd) is one of the s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dcee20c1cc6d2c18b10e4db2b3a08085
https://doi.org/10.1016/j.clml.2019.04.009
https://doi.org/10.1016/j.clml.2019.04.009
Autor:
Binyan Wang, Jie Jiang, Nan Luo, Xiaobin Wang, Alex Z. Fu, Xiping Xu, Zhuoru Liang, Tengfei Lin, Lishun Liu, Tiantian Zhang
Publikováno v:
Quality of Life Research. 28:2069-2080
Hypertension is a major global public health problem, including rural China. However, studies examining health-related quality of life (HRQoL) for patients with hypertension have been mostly conducted in urban populations. This study aimed to use the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be303f7858e524df776e849f9502d816
https://doi.org/10.1007/s11136-019-02139-3
https://doi.org/10.1007/s11136-019-02139-3
Publikováno v:
Leukemia & Lymphoma. 60:610-618
Ixazomib, as a proteasome inhibitor, inhibits the chymotrypsin-like activity of the β5 subunit of the 20S proteasome. Based on the TOURMALINE-MM1 study, ixazomib was proved by the FDA as the orphan drug in November 2015. With a promising effect in p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b238cf47e7f322ff4673f60158bb642
https://doi.org/10.1080/10428194.2018.1523398
https://doi.org/10.1080/10428194.2018.1523398
Autor:
Tengfei Lin, Tiantian Zhang, Lishun Liu, Zhuoru Liang, Zhihao Yang, Yongmei Xu, Peiyao Lu, Binyan Wang, Nan Luo, Jie Jiang, Yanming Hong
Publikováno v:
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 30(7)
The purpose of this study was to compare the measurement properties of two versions of EQ-5D (i.e.EQ-5D-3L and EQ-5D-5L) in hypertensive patients in rural China. A cross-sectional survey was carried out in hypertensive patients in rural China. We com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93a67739d41b936f4b6d1bf6b85547aa
https://pubmed.ncbi.nlm.nih.gov/33821418
https://pubmed.ncbi.nlm.nih.gov/33821418
Autor:
Zhuoru Liang, Tiantian Zhang, Jingmei Xie, Sen Wang, Bing Situ, Dan Qian, Ying Zhang, Peiying Zheng, Lina Zhao
Publikováno v:
Diabetes Therapy
We assessed the efficacy and safety of oral antidiabetic drugs (OADs) as an add-on treatment in patients with type 2 diabetes uncontrolled on metformin. PubMed, the Cochrane Library, and Embase were searched from inception to October 20, 2017. Pairwi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5ef01e7d541da115976bcc8c6d8f6b1
https://doi.org/10.1007/s13300-018-0482-5
https://doi.org/10.1007/s13300-018-0482-5